Articles related to RISK ASSESSMENT

The PREVENT equation, developed by the American Heart Association in 2023, aims to provide a more accurate cardiovascular risk assessment for today’s population, potentially reducing statin prescriptions by 40%.

Prostate cancer screening guidelines that use race as a criterion are under ethical scrutiny, with experts calling for a shift towards universal, unbiased risk assessment that addresses socioeconomic factors and healthcare access disparities.

Infrequent soft stools were associated with higher risks of all-cause, cancer, and cardiovascular disease mortality, suggesting that stool monitoring could be a valuable indicator of major chronic illnesses.

Recent findings indicate that statin-naïve ACS patients with normal LDL-C levels at admission may face worse outcomes, challenging current perspectives on lipid management in cardiovascular care.

Statins remain a cornerstone of cardiovascular disease prevention, but managing potential side effects is key to ensuring patient adherence and optimal outcomes. This article provides a comprehensive overview of statin-associated adverse effects and practical management strategies for clinicians.

A comprehensive study spanning over two decades has found no evidence that daily multivitamin use reduces the risk of death from any cause, including cancer and cardiovascular disease.